The U.S. Drug Enforcement Administration (DEA) triggered high hopes when it recently announced it wants to accept the U.S. Department of Health and Human Services’ recommendation to reschedule marijuana from Schedule I to Schedule III.
Josh Horn, Co-Chair and co-founder of our Cannabis Law Practice, joins host Matt Adams to explore this trailblazing announcement by the DEA.
Their discussion digs into the business and banking ramifications of the potential rescheduling See more +
The U.S. Drug Enforcement Administration (DEA) triggered high hopes when it recently announced it wants to accept the U.S. Department of Health and Human Services’ recommendation to reschedule marijuana from Schedule I to Schedule III.
Josh Horn, Co-Chair and co-founder of our Cannabis Law Practice, joins host Matt Adams to explore this trailblazing announcement by the DEA.
Their discussion digs into the business and banking ramifications of the potential rescheduling for cannabis companies. They also explore social justice issues for people formerly incarcerated for nonviolent crimes related to the possession and use of marijuana. And they examine the parallels to Prohibition as well as consider the benefits rescheduling could have for medical research and municipal revenue generation. See less -
